Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
Pheezee is designed to assess musculoskeletal and neuromuscular health.
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
Subscribe To Our Newsletter & Stay Updated
